About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Houston | 138 Studies

Clinical Trials Brain CancerHouston

Brain Cancer Clinical Trials in Houston

Find 138 clinical trials for brain cancer near Houston, Texas. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 138 trials

CompletedCilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)This study will investigate clinical activity, safety, and tolerability of the anti-angiogenic compound cilengitide (EMD 121974) in the treatment of first recurrence of…NCT00093964·Birmingham, Alabama and 16 others RecruitingSafety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP LossThis is a first in human study of TNG456 alone and in combination with abemaciclib in patients with advanced or metastatic solid tumors known to have an MTAP loss.NCT06810544·Scottsdale, Arizona and 14 others

Brain Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

UnknownCombination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed GliomasRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00278278·Houston, Texas

CompletedTemozolomide and Carmustine in Treating Patients With Anaplastic GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003176·Los Angeles, California and 9 others

CompletedVorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsThis phase I trial is studying the side effects and best dose of vorinostat when given together with temozolomide in treating young patients with relapsed or refractory primary…NCT01076530·Chicago, Illinois and 8 others

TerminatedSafety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.This is a Phase 1, First-in-Human (FIH), open-label, multicenter, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics and preliminary…NCT05831995·San Francisco, California and 5 others

CompletedDasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or GliosarcomaThis phase II trial studies how well dasatinib works in treating patients with glioblastoma multiforme or gliosarcoma that has come back.NCT00423735·Mobile, Alabama and 187 others

CompletedSorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or GliosarcomaThis phase I/II trial is studying the side effects and best dose of erlotinib, tipifarnib, and temsirolimus when given together with sorafenib and to see how well they work in…NCT00335764·Los Angeles, California and 6 others

CompletedImatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or MeningiomaRATIONALE: Imatinib mesylate may interfere with the growth of tumor cells and may be an effective treatment for recurrent glioma and meningioma.NCT00010049·Los Angeles, California and 10 others

CompletedTemozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma MultiformeRATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from…NCT00112502·Fort Smith, Arkansas and 11 others

CompletedComputer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma MultiformeRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.NCT00003417·Birmingham, Alabama and 236 others

CompletedGefitinib in Treating Patients With Recurrent or Progressive CNS TumorsRATIONALE: Biological therapies such as gefitinib may interfere with the growth of tumor cells and slow the growth of CNS tumors.NCT00025675·Los Angeles, California and 11 others

CompletedA Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial TherapyThis is an event driven, adaptive design, a randomized, active-controlled, multicenter, open-label, parallel groups, Phase 3 study of DSP-7888 Dosing Emulsion plus Bevacizumab…NCT03149003·Birmingham, Alabama and 60 others

RecruitingStudy of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)The goal of this Phase I clinical trial is to evaluate how the imaging drug 203Pb- RMX-VH-PIB distributes in the body and how much radiation different organs receive in patients…NCT07733674·Houston, Texas

Active not recruitingA Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2This research study is evaluating an investigational drug, an oncolytic virus called rQNestin34.5v.2.NCT03152318·Baltimore, Maryland and 4 others

UnknownStudy of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain CancerThe primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM for whom surgery is indicated.NCT00045968·Birmingham, Alabama and 85 others

CompletedPazopanib in Treating Patients With Recurrent GlioblastomaThis phase II trial is studying the side effects and how well pazopanib works in treating patients with recurrent glioblastoma.NCT00459381·Los Angeles, California and 8 others

CompletedVerubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma MultiformeThis, international, multi-center, Phase 2 study of verubulin will be conducted in patients with newly diagnosed Glioblastoma Multiforme (GBM).NCT01285414·Stanford, California and 1 other

CompletedStudy of Tesevatinib Monotherapy in Patients With Recurrent GlioblastomaThis is a multicenter, Phase 2 study to assess the activity of tesevatinib in patients with recurrent glioblastoma.NCT02844439·Tucson, Arizona and 10 others

Active not recruitingPediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPGIndoximod was developed to inhibit the IDO (indoleamine 2,3-dioxygenase) enzymatic pathway, which is important in the natural regulation of immune responses.NCT04049669·Augusta, Georgia and 4 others

PreviousPage 3 of 7Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia